British study shows Clinuvel drug effective on DNA of UV-damaged skin
Clinuvel Pharmaceuticals Ltd (ASX:CUV) has announced positive final results from a British-conducted…
Clinuvel Pharmaceuticals Limited (ASX:CUV)
About Clinuvel Pharmaceuticals Limited
Key Information
CUV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 23/12/2024 | Managing Director Letter to Shareholders | 96.75KB | 1.6K |
| 23/12/2024 | Price Sensitive PS Health Canada validates SCENESSE New Drug Submission | 68.68KB | 787 |
| 18/12/2024 | Revised Securities Trading Policy | 211.55KB | 1.0K |
| 06/12/2024 | Becoming a substantial holder | 1.24MB | 3.3K |
| 05/12/2024 | Price Sensitive PS Chair's letter to Shareholders | 83.86KB | 18K |
| 04/12/2024 | Notification of cessation of securities - CUV | 12.69KB | 414 |
| 20/11/2024 | Price Sensitive PS SCENESSE dosage expansion under review by EMA | 87.02KB | 27K |
| 18/11/2024 | CLINUVEL Bell Potter Healthcare Conference Presentation | 430.71KB | 1.4K |